COMMUNIQUÉS West-GlobeNewswire

Leigh Elkolli Promoted to Chief Financial Officer at REVA Medical

03/01/2019 - 22:44

SAN DIEGO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announced the promotion of Leigh Elkolli to [...]

XOMA Announces Barbara Kosacz Joins its Board of Directors

03/01/2019 - 22:35

EMERYVILLE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today Barbara Kosacz, a Partner at Cooley LLP, has joined the Company’s Board of Directors. Ms. Kosacz is the international [...]

Retrophin Names Eric Dube, Ph.D. President and Chief Executive Officer

03/01/2019 - 22:30

Dr. Dube brings proven track record of global leadership built upon significant commercial and operational success Dr. Dube succeeds Stephen Aselage, who will continue serving on Board SAN DIEGO, Jan. 03, 2019 (GLOBE [...]

Profound Medical Announces Preliminary Unaudited Fourth Quarter 2018 Revenues

03/01/2019 - 22:30

TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that combines real-time Magnetic Resonance (“MR [...]

Terra Tech to Host Grand Opening Ceremony of its Medical Cannabis Dispensary in San Leandro, CA on January 11, 2019

03/01/2019 - 22:15

Mayor Pauline Cutter to speak at ribbon cutting ceremony IRVINE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Terra Tech Corp. ( TRTC ) ("Terra Tech") or (the "Company"), a vertically integrated cannabis-focused [...]

MRI Interventions Announces Estimated 30% Growth Driven by Record Revenue and Record ClearPoint® Procedure Volume in 2018 Fourth Quarter

03/01/2019 - 22:15

IRVINE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation in procedures for deep brain stimulation, ablation, [...]

Selecta Biosciences Expands Potential for ImmTOR™ Platform and Streamlined Structure Under Leadership of New CEO, Carsten Brunn, Ph.D.

03/01/2019 - 22:11

Reported completion of SEL-212 Phase 2 study with positive efficacy and tolerability results observed in the clinical trial, in addition to monthly dosing, indicating potential to serve unmet need for patients with [...]

Dynavax to Present at 37th Annual J.P. Morgan Healthcare Conference

03/01/2019 - 22:05

BERKELEY, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel vaccines and immuno-oncology [...]

CASMED Reports Preliminary Net Sales for the 2018 Fourth Quarter and Full Year

03/01/2019 - 22:05

Record Q4 FORE-SIGHT® cerebral oximetry sales drive 18% full-year FORE-SIGHT sales growth Introduces 2019 FORE-SIGHT sales guidance BRANFORD, Conn., Jan. 03, 2019 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: [...]

GBT Announces New Employment Inducement Grants

03/01/2019 - 22:05

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT or the Company) (NASDAQ: GBT) today announced that, on January 1, 2019, the compensation committee of the Company’s [...]

Humanigen Announces Publication Demonstrating EphA3 Receptor as an Attractive Antibody Target for Brain Cancer and Other Solid Tumor Therapy in the Journal ‘Cancers’

03/01/2019 - 22:05

Study Demonstrates a Significant Increase in Overall Survival in Mice Robust Anti-tumor Response with No Toxicity Using EphA3 Antibody Drug Conjugate (ADC) and Radioimmunotherapy (RIT) Approaches Provides Evidence that [...]

Novavax Announces Positive Phase 2 NanoFlu Results in Older Adults

03/01/2019 - 22:05

Sets the Stage for Phase 3 Clinical Trial in 2019 Phase 2 clinical trial confirmed Phase 1/2 results, again demonstrating improved immune responses over Fluzone ® High-Dose End-of-Phase 2 meeting with the FDA expected [...]

MRI Interventions Receives FDA Clearance for ClearPoint® PURSUIT™ Neuro Aspiration System

03/01/2019 - 22:05

Limited Market Release Marks the First Internally Developed Therapeutic Product Added to the Company Portfolio IRVINE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform [...]

Amicus Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

03/01/2019 - 22:01

CRANBURY, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will present a corporate overview at the 37 th Annual J.P [...]

Reata Announces Clinical Trial Design for FALCON, a Phase 3 Trial of Bardoxolone Methyl for the Treatment of Autosomal Dominant Polycystic Kidney Disease

03/01/2019 - 22:01

IRVING, Texas, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that it has completed a successful end-of-Phase 2 meeting with the [...]

Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2018 Revenue and Initial Revenue Guidance for 2019

03/01/2019 - 22:01

Fourth-quarter 2018 revenue estimated to be approximately $9.5 million, an increase of 36% over the previous quarter Full-year 2018 revenue estimated to be approximately $22.5 million Flexion providing initial 2019 [...]

Repligen to Present at 37th Annual J.P. Morgan Healthcare Conference

03/01/2019 - 19:26

WALTHAM, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at the 37 th Annual J.P [...]

Eloxx Pharmaceuticals to Participate in a Panel Discussion at the BIOTECH SHOWCASE™ in San Francisco on Wednesday, January 9, 2019

03/01/2019 - 19:08

WALTHAM, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]

Quality improvement interventions improve efficacy of depression screening and follow-up

03/01/2019 - 19:00

Study appears in January 2019 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Depression is the leading cause of disability and often goes [...]